scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1423-0410.1994.TB00297.X |
P698 | PubMed publication ID | 8184597 |
P2093 | author name string | Lucas GF | |
P2860 | cites work | Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets | Q41012474 |
P433 | issue | 2 | |
P921 | main subject | immunofluorescence microscopy | Q592324 |
chemiluminescence | Q2931725 | ||
P304 | page(s) | 141-147 | |
P577 | publication date | 1994-01-01 | |
P1433 | published in | Vox Sanguinis | Q15708866 |
P1476 | title | Prospective evaluation of the chemiluminescence test for the detection of granulocyte antibodies: comparison with the granulocyte immunofluorescence test | |
P478 | volume | 66 |
Q43556866 | A randomized controlled trial oftransfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? |
Q44996213 | An International reference reagent for the detection of anti-human neutrophil antigen-1a |
Q41114256 | Challenges in the determination of clinically significant granulocyte antibodies and antigens |
Q50480683 | External quality assessment of human neutrophil antigen (HNA)-specific antibody detection and HNA genotyping from 2000 to 2012. |
Q71697913 | Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash |
Q78130942 | Immune-mediated neutropenia in 2 dogs |
Q40505251 | Neutrophil antigens, from bench to bedside |
Q50665720 | Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome. |
Q50506462 | Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. |
Q53313680 | Report on the Fourth International Granulocyte Immunology Workshop: progress toward quality assessment. |
Q33339027 | The effect of treatment with Campath-1H in patients with autoimmune cytopenias |
Q47576193 | The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma. |
Q33330518 | Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor |
Search more.